Description
This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 7
Primary Industries
- Medical
- Diagnostic
- Device
- Scientific & Technical Instruments
- Drugs
- Biotechnology
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 1271
License Grant
Licensor hereby grants an exclusive license under the PE Technology and PE Intellectual Property upon the terms and conditions of this Agreement to make, have made for it, use, and sell Licensed Products throughout the Territory for use only in the field of Medical Diagnostics, but excluding Nucleic Acid Diagnostics.
License Property
'SPR' means surface plasmon resonance. 'SPR Technology' means the use of thin conductive films on a surface or surfaces of a grating or other diffracting substrate to conduct chemical analysis.
IPSCIO Record ID: 27725
License Grant
The Japanese Licensor grants to Licensee the non-exclusive license to develop, manufacture, sell and have sold the Licensee Products incorporating Licensor's Technology in Non-Pacific Rim Territories for the Medical Diagnostics Field.
License Property
Chip means a substrate which contains a grating pursuant to the Grating SPR Technology and is coated with a conductive surface.
Flow Cell means a device which allows liquids to flow through it and consist of a Chip and has an optically clear cover slip which is attached to the Chip by a means that allows for fluid flow there through.
Grating SPR Technology means the use of thin conductive films on a surface or surfaces of a grating or other diffracting substrate to conduct chemical analysis.
PATENT NO. TITLE JAPANESE PATENT NO.
—————————————————————————————-
US 4,931,384 Optical Assay Technique (Merlin I) JP 1903195
US 5,118,608 Optical Assay Technique (Merlin I) JP 2502222
US 4,882,288 Assay Technique and Equipment JP 1928364
(Merlin II)
US 4,992,385 Polymer-Coated Optical Structures JP 2528134
and Methods of Making and Using JP 2592588
the Same (Cellulose Nitrate Films)
US 4,828,387 Film Measuring Device and Method JP 2511057
with Internal Calibration to
Minimize the Effect of Sample
Movement (Calibration Notches)
US 5,310,686 Polymer-Coated Optical Structures JP 2710243
(Sensor Using Photoresist)
CA 1,302,875 (Waveguide Sensor) JP 2572829
US 6,093,536 (Enhanced SPR Assay) JP 2073383
Field of Use
This agreement pertains to the medical diagnostics field. Medical Diagnostics Field means those fields, the applications and products which under current laws and regulations of the United States would require approval of the United States Food and Drug Administration if the application or product incorporating the application were sold for clinical use in the United States.
IPSCIO Record ID: 30040
License Grant
In this Joint Venture/Partnership, where Licensor and a Third Party created Licensee, a license is provided for nonmedical use of the High Density Technology, one of the SPR prototype instruments, and the prototype for the High Density Technology and a sub-license to all of its rights to the Company's SPR nonmedical technology.
License Property
Surface Plasmon Resonance (SPR) technology is an instrument which will run various tests capable of diagnosing various human health conditions.
Field of Use
This agreement pertains to commercialization consisting of developing and introducing an instrument which will run various tests capable of diagnosing various human health conditions and which the Company intends to market to the world medical diagnostic industry.
IPSCIO Record ID: 26242
License Grant
By the party to the other party; Company A hereby grants to Company B of Japan the sole and exclusive license and sublicense under the Company A Patents and Company A Technology to develop, manufacture, have manufactured, sell or have sold Company B Products for the Field of Research Applications in Japan. Company B grants to Company A the non-exclusive license to develop, manufacture, sell and have sold the Company A Products incorporating Company B Technology in Non-Pacific Rim Territories for the Field of Research Applications.
License Property
Chip means a substrate which contains a grating pursuant to the Grating SPR Technology and is coated with a conductive surface.
Flow Cell means a device which allows liquids to flow through it and consist of a Chip and has an optically clear cover slip which is attached to the Chip by a means that allows for fluid flow there through.
Grating SPR Technology means the use of thin conductive films on a surface or surfaces of a grating or other diffracting substrate to conduct chemical analysis.
US 4,931,384 Optical Assay Technique (Merlin I) JP 1903195
US 5,118,608 Optical Assay Technique (Merlin I) JP 2502222
US 4,882,288 Assay Technique and Equipment (Merlin II) JP 1928364
US 4,992,385 Polymer-Coated Optical Structures and JP 2528134
Methods of Making and Using the Same JP 2592588
(Cellulose Nitrate Films)
US 4,828,387 Film Measuring Device and Method with JP 2511057
Internal Calibration to Minimize the Effect
of Sample Movement (Calibration Notches)
US 5,310,686 Polymer-Coated Optical Structures (Sensor JP 2710243
Using Photoresist)
CA 1,302,875 (Waveguide Sensor) JP 2572829
US 6,093,536 (Enhanced SPR Assay) JP 2073383
Optical Array JP Application #
JP 2000-524645
Field of Use
Medical Diagnostics Field means those fields, the applications and products which under current laws and regulations of the United States would require approval of the United States Food and Drug Administration if the application or product incorporating the application were sold for clinical use in the United States.
Field of Research Applications means the field of target discovery and validation for pharmaceutical and diagnostic research; the Field of Research Applications expressly excludes the Medical Diagnostics Field, food testing applications and environmental testing applications.
IPSCIO Record ID: 1796
License Grant
The Company acquired at a total cost of $3.4 million a worldwide exclusive license to certain patents, proprietary information and associated hardware (e.g. molds, test rigs, prototypes) related to the SPR (surface plasmon resonance) technology; multi-test critical care DBx diagnostic system.
License Property
The DBx uses Licensee’s proprietary and robust digital biosensor Surface Plasmon Resonance (SPR) technology. The use of SPR by Licensee enables it to integrate multiple diagnostic methodologies, such as immunoassays, DNA probes and chemical binding, into a single, simple system. This flexibility should allow the DBx to provide an extensive menu of rapid, quantitative STAT tests in critical care units; surface plasmon resonance (SPR), which involves the interaction of light with electrons. Licensee’s technology creates SPR in a controlled environment which enables its instrument to detect and transmit information concerning the presence and quantity of certain native and foreign molecules in blood, urine or other fluids which may be associated with specific diseases or medical conditions.
Field of Use
A biosensor is an analytical device that combines a biological sensing or detection element with a suitable transducer that converts biochemical activity into a measurable form of energy.
IPSCIO Record ID: 27230
License Grant
The Company hereby grants to Licensee an exclusive license under the Serono Technology and the Company’s Intellectual Property upon the terms and conditions of this Agreement to make, have made for it, use, and sell Licensed Products throughout the Territory for all fields, but excluding the following listed in the Agreement.
License Property
Through the optical and chemistry deposition advancements made by PE, they are able to read up to 100 test areas on a single 1 cm by 1 cm SPR disposable and plan to expand capacity to beyond 5,000 tests within the same area. Such two dimensional (2D) array capability, as now used in genomic screening research, puts the Company on the leading edge of micro lab/lab on chip pursuits that are expected to redefine diagnostic testing. Four phases of assistance have been established with a reduction in the Licensee’s royalty each time a phase is completed. Phase I and II have been completed.
Field of Use
The rights granted apply to all fields, but excluding the following
1) Medical Diagnostics 2) any confidential information of a third party which the Company is prevented from disclosing to PE under an obligation of confidentiality to a third party or 3) any license (other than the Serono Agreement) the Company obtains under a third party's technology unless that license permits the Company to sublicense to Licensee the third party's technology.
IPSCIO Record ID: 155359
License Grant
The parties are amending terms to a license under the third party technology and a license to certain Licensee technology described in a patent application.
Royalty rates are amended.
The non-exclusive license granted to Licensee to Sell Licensed Products throughout the Territory for Nucleic Acid Diagnostics is terminated, effective the date of this Amendment to License Agreement.
This amendment deletes the words ', but excluding Nucleic Acid Diagnostics', so that the Licensors License will no longer exclude Nucleic Acid Diagnostics.
License Property
Licensee technology is a patent application entitled Surface Plasmon Array System.
Field of Use
The rights granted apply to all fields, but excluding the following1) Medical Diagnostics 2) any confidential information of a third party which the Company is prevented from disclosing to Licensee under an obligation of confidentiality to a third party or 3) any license (other than the third party Agreement) the Company obtains under a third partys technology unless that license permits the Company to sublicense to Licensee the third partys technology.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.
